ES8600401A1 - Un procedimiento para la preparacion de nuevos derivados de furanona (sustancia fr 51785) - Google Patents

Un procedimiento para la preparacion de nuevos derivados de furanona (sustancia fr 51785)

Info

Publication number
ES8600401A1
ES8600401A1 ES530709A ES530709A ES8600401A1 ES 8600401 A1 ES8600401 A1 ES 8600401A1 ES 530709 A ES530709 A ES 530709A ES 530709 A ES530709 A ES 530709A ES 8600401 A1 ES8600401 A1 ES 8600401A1
Authority
ES
Spain
Prior art keywords
preparation
substance
furanone derivatives
new
new furanone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES530709A
Other languages
English (en)
Other versions
ES530709A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of ES530709A0 publication Critical patent/ES530709A0/es
Publication of ES8600401A1 publication Critical patent/ES8600401A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14Unsaturated ethers
    • C07C43/164Unsaturated ethers containing six-membered aromatic rings
    • C07C43/166Unsaturated ethers containing six-membered aromatic rings having unsaturation outside the aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58One oxygen atom, e.g. butenolide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/60Two oxygen atoms, e.g. succinic anhydride
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/04Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE NUEVOS DERIVADOS DE FURANONA (SUSTANCIA FR-51785).COMPRENDE: A) CULTIVAR UNA CEPA CHAETONELLA, EN UN MEDIO NUTRIENTE QUE CONTIENE FUENTES DE CARBONO Y NITROGENO ASIMILABLES EN CONDICIONES AEROBICAS, COMO GLUCOSA, GLICERINA, HARINA DE GLUTEN, INFUSION DE MAIZ Y OTROS, A UNA TEMPERATURA ENTRE 9J Y 39JC, Y A UN PH ENTRE 2 Y 7 Y B) RECUPERAR LA SUSTANCIA FR-51785 DEL MEDIO DE CULTIVO, MEDIANTE FILTRACION O CENTRIFUGACION.
ES530709A 1982-07-19 1984-03-16 Un procedimiento para la preparacion de nuevos derivados de furanona (sustancia fr 51785) Expired ES8600401A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57126599A JPS5916884A (ja) 1982-07-19 1982-07-19 新規フラン化合物

Publications (2)

Publication Number Publication Date
ES530709A0 ES530709A0 (es) 1985-05-16
ES8600401A1 true ES8600401A1 (es) 1985-05-16

Family

ID=14939171

Family Applications (5)

Application Number Title Priority Date Filing Date
ES524274A Granted ES524274A0 (es) 1982-07-19 1983-07-19 Un compuesto.
ES530709A Expired ES8600401A1 (es) 1982-07-19 1984-03-16 Un procedimiento para la preparacion de nuevos derivados de furanona (sustancia fr 51785)
ES530710A Expired ES8604552A1 (es) 1982-07-19 1984-03-16 Un procedimiento para la preparacion de nuevos derivados de furanona
ES530708A Expired ES8604551A1 (es) 1982-07-19 1984-03-16 Un procedimiento para la preparacion de nuevos derivados de furanona
ES530707A Expired ES8600264A1 (es) 1982-07-19 1984-03-16 Un procedimiento para la preparacion de nuevos derivados de furanona

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES524274A Granted ES524274A0 (es) 1982-07-19 1983-07-19 Un compuesto.

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES530710A Expired ES8604552A1 (es) 1982-07-19 1984-03-16 Un procedimiento para la preparacion de nuevos derivados de furanona
ES530708A Expired ES8604551A1 (es) 1982-07-19 1984-03-16 Un procedimiento para la preparacion de nuevos derivados de furanona
ES530707A Expired ES8600264A1 (es) 1982-07-19 1984-03-16 Un procedimiento para la preparacion de nuevos derivados de furanona

Country Status (9)

Country Link
US (2) US4585789A (es)
EP (1) EP0099692B1 (es)
JP (1) JPS5916884A (es)
KR (1) KR840005439A (es)
AT (1) ATE25977T1 (es)
CA (1) CA1221929A (es)
DE (1) DE3370327D1 (es)
DK (1) DK330783A (es)
ES (5) ES524274A0 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5916884A (ja) * 1982-07-19 1984-01-28 Fujisawa Pharmaceut Co Ltd 新規フラン化合物
EP0189272A3 (en) * 1985-01-17 1987-08-19 Fujisawa Pharmaceutical Co., Ltd. New furanone derivatives, processes for preparation thereof and use thereof
US4707499A (en) * 1985-12-02 1987-11-17 G. D. Searle & Co. 3-alkyl-5-(substituted amino)methyl)dihydro-3-phenyl-2(3H)-furanones and imino analogs thereof used for treatment of arrhythmia
DE3615157A1 (de) * 1986-05-05 1987-11-12 Schwabe Willmar Gmbh & Co 5-arylalkyl-4-alkoxy-2(5h)-furanone, zwischenprodukte und verfahren zu ihrer herstellung sowie ihre anwendung als therapeutische wirkstoffe
CA1320728C (en) * 1987-09-07 1993-07-27 Kazuhiko Sakaguchi Liquid crystalline compounds and process for production thereof
JPH0222271A (ja) * 1988-07-11 1990-01-25 Kuraray Co Ltd 共役γ−オキシブテノライド化合物およびこれを有効成分とする抗潰瘍剤
JP2790335B2 (ja) * 1989-09-20 1998-08-27 株式会社クラレ 共役γ―オキシブテノライド化合物およびこれを有効成分とする抗潰瘍剤
DE4014420A1 (de) * 1989-09-23 1991-04-04 Bayer Ag 5h-furan-2-on-derivate
JP3068706B2 (ja) * 1992-02-26 2000-07-24 塩野義製薬株式会社 アルド−ス還元酵素阻害物質
US6492413B2 (en) * 1993-01-15 2002-12-10 G.D. Searle & Co. 3.4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
KR960703901A (ko) * 1993-08-19 1996-08-31 로즈 암스트롱 치환된 2(5H)푸라논, 2(5H)티오페논 및 2(5H)피롤론 유도체, 그의 제조 방법 및 엔도텔린 길항제로서의 그의 용도(Substituted 2(5H)Furanone, 2(5H)Thiophenone and 2(5H)Pyrrolone Derivatives, Their Preparation and Their Use as Endothelin antagonists)
US5698585A (en) 1995-04-13 1997-12-16 Kikkoman Corporation Pharmaceutical preparation for prevention and/or treatment for cataract
US5922759A (en) * 1996-06-21 1999-07-13 Warner-Lambert Company Butenolide endothelin antagonists
AU6603996A (en) * 1995-08-24 1997-03-19 Warner-Lambert Company Furanone endothelin antagonists
GB9615867D0 (en) * 1996-07-03 1996-09-11 Merck & Co Inc Process of preparing phenyl heterocycles useful as cox-2 inhibitors
US5891892A (en) * 1996-10-29 1999-04-06 Warner-Lambert Company Small molecule biaryl compounds as inhibitors of endothelin converting enzyme
US6355593B1 (en) 2000-09-01 2002-03-12 Exxonmobil Research And Engineering Company Fischer-Tropsch catalyst enhancement
US6753351B2 (en) 2002-01-29 2004-06-22 Exxonmobil Research And Engineering Company Supported catalyst activation
US7419928B2 (en) * 2003-04-11 2008-09-02 Exxonmobil Research And Engineering Company Fischer-Tropsch catalyst production
US7361619B2 (en) * 2003-04-11 2008-04-22 Exxonmobil Research And Engineering Company Fischer-Tropsch catalyst production
EP2746266A1 (en) * 2012-12-19 2014-06-25 Basf Se New substituted triazoles and imidazoles and their use as fungicides

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2841594A (en) * 1958-07-01 Production of beta-furoic acids
US3113939A (en) * 1959-05-28 1963-12-10 Du Pont Substituted maleic anhydrides and the corresponding lactones of 3-formylacrylic acid
US3509209A (en) * 1967-01-12 1970-04-28 Union Oil Co Hydrocarboxylation of certain conjugated diolefin compounds
US3873575A (en) * 1967-02-17 1975-03-25 Spofa Vereinigte Pharma Werke {65 -4-N-butoxyphenyl-{60 ,{62 -dibromo-{66 {300 ,{330 -crotonic acid lactone
US3564020A (en) * 1968-07-17 1971-02-16 Union Oil Co Preparation of angelica lactone
GB1228185A (es) * 1968-09-17 1971-04-15
US3813416A (en) * 1969-02-17 1974-05-28 Mobil Oil Corp Substituted gamma-butyrolactones derived from c16 and greater unsaturated acids
DE1920176A1 (de) * 1969-04-21 1970-10-22 Thomae Gmbh Dr K Neues Verfahren zur Herstellung von Hydroxycrotonsaeurelaktonen
US3838168A (en) * 1969-11-21 1974-09-24 Dow Chemical Co Alpha-methylenation of gamma-butyrolactones
US3826839A (en) * 1970-12-03 1974-07-30 Smithkline Corp Anti-arthritic compositions comprising ester derivatives of pulvinic acid and methods of producing anti-arthritic activity
US3940424A (en) * 1973-12-19 1976-02-24 Monsanto Company Lactones
US4010170A (en) * 1975-09-24 1977-03-01 Iowa State University Research Foundation, Inc. Butenolide synthesis via carbonylation of vinylmercurials
US4214092A (en) * 1979-02-21 1980-07-22 Iowa State University Research Foundation, Inc. Rearrangement of acyloxy furans and thiophenes prepared from butenolides
FR2456097A1 (fr) * 1979-05-07 1980-12-05 Delalande Sa Nouveaux derives de la 5 h-furanone-2 et de la 3 h-dihydrofuranone-2, leur procede de preparation et leur application en therapeutique
US4508914A (en) * 1979-12-22 1985-04-02 Dynamit Nobel Ag 3H-Furanones
JPS5916884A (ja) * 1982-07-19 1984-01-28 Fujisawa Pharmaceut Co Ltd 新規フラン化合物

Also Published As

Publication number Publication date
ES8600263A1 (es) 1985-05-01
CA1221929A (en) 1987-05-19
ES530708A0 (es) 1986-02-01
DE3370327D1 (en) 1987-04-23
ATE25977T1 (de) 1987-04-15
US4797417A (en) 1989-01-10
ES530707A0 (es) 1985-05-16
JPS5916884A (ja) 1984-01-28
JPH0352458B2 (es) 1991-08-12
DK330783D0 (da) 1983-07-18
ES8604551A1 (es) 1986-02-01
EP0099692A1 (en) 1984-02-01
DK330783A (da) 1984-03-05
ES8600264A1 (es) 1985-05-16
EP0099692B1 (en) 1987-03-18
ES524274A0 (es) 1985-05-01
ES8604552A1 (es) 1986-02-01
ES530709A0 (es) 1985-05-16
ES530710A0 (es) 1986-02-01
KR840005439A (ko) 1984-11-12
US4585789A (en) 1986-04-29

Similar Documents

Publication Publication Date Title
ES8600401A1 (es) Un procedimiento para la preparacion de nuevos derivados de furanona (sustancia fr 51785)
ES458982A1 (es) Un proceso para la produccion de glicerol y sustancias pro- teinicas de valor nutritivo.
UA37253C2 (uk) Спосіб вилучення нафти із резервуара (варіанти)
ES432181A1 (es) Procedimiento para la obtencion de la sustancia antibioticalipiarmicina.
ES455714A1 (es) Procedimiento de fabricacion de soportes para filtros biolo-gicos.
DK343088A (da) Pyrazinderivater, fremgangsmaade til fremstilling heraf, midler indeholdende disse og fremgangsmaader til regulering af plantevaekst
ES412270A1 (es) Metodo para preparar arabinofuranosil citosinas.
ES470549A1 (es) Procedimiento para la obtencion de proteinas alimenticias
ES444311A1 (es) Un procedimiento de lisis del residuo micelar obtenido en laproduccion de antibioticos.
JPS5399397A (en) Method for preparing amino acids, nucleic acids or organic acids
JPS5414589A (en) Preparation of bacterial cells
ES8301277A1 (es) Un procedimiento para la preparacion de una nueva sustancia antibiotica sf-2103a.
JPS5675095A (en) Preparation of heat-resistant acetic acid kinase
JPS5228986A (en) Device for continuous culture of microorganisms or animal and plant ti ssues
JPS5432686A (en) Flocculation of microorganisms
JPS5299282A (en) Preparation of yeast cells
SU542766A1 (ru) Способ автоматического управлени процессом непрерывного выращивани микроорганизмов
JPS5396379A (en) Peocess for producing microbial cells
JPS5414587A (en) Preparation of bacterial cells
JPS52148683A (en) Treatment of microbial cultivation liquid
ES458780A1 (es) Metodo para cultivar microorganismos aerobicamente.
ES445460A1 (es) Procedimiento de obtencion de sustancias inhibidoras del crecimiento bacteriano.
ES404603A1 (es) Un procedimiento para la produccion de espectinomicina.
ES486579A1 (es) Un procedimiento para preparar una vacuna intra-respiratoria
ES427754A1 (es) Un procedimiento para preparar beta-galactosidasa.